cell
surfac
variou
function
commun
cell
integr
tissu
interact
extracellular
matrix
proteas
play
key
role
process
review
focus
cellsurfac
peptidas
ectopeptidas
oligopeptidas
involv
inactiv
activ
extracellular
regulatori
peptid
hormon
paracrin
peptid
cytokin
neuropeptid
nomenclatur
cellsurfac
peptidas
explain
relat
proteas
inform
provid
membran
anchor
catalyt
site
regul
particular
physiolog
pharmacolog
import
furthermor
nonenzymat
bind
function
particip
intracellular
signal
transduct
cell
surfac
peptidas
describ
overview
differ
cellsurfac
peptidas
given
diverg
function
explain
detail
exampl
actual
pharmacolog
import
dipeptidylpeptidas
iv
discuss
secret
cell
type
proteas
may
fulfil
similar
function
cellsurfac
proteas
appear
gener
regulatori
special
function
secret
one
particular
involv
regul
activ
peptid
commun
cell
tissu
oligopeptidas
cellsurfac
peptidas
origin
sens
degrad
extracellular
compon
matrix
proteas
shed
cellsurfac
protein
secretas
sheddas
sinc
compris
broad
spectrum
diver
type
proteas
review
focus
cellsurfac
oligo
peptidas
tabl
special
group
cellsurfac
proteas
involv
regul
biolog
activ
small
bioactiv
peptid
serv
cell
commun
name
peptid
hormon
neuropeptid
growth
factor
cytokin
import
physiolog
role
focus
attent
cellsurfac
peptidas
recent
pharmacolog
research
inhibitor
wide
use
drug
develop
review
provid
overview
gener
properti
physiolog
pharmacolog
import
mammalian
cellsurfac
oligo
peptidas
closer
view
given
select
peptidas
actual
pharmacolog
interest
dipeptidylpeptidas
iv
type
cellsurfac
proteas
act
mainli
larger
proteinproteoglycan
substrat
membranetyp
matrix
metalloproteinas
mtmmp
belong
group
matrix
metalloproteinas
mmp
primarili
involv
degrad
extracellular
matrix
compon
mmp
mostli
secret
cellsurfac
mtmmp
either
act
like
secret
mmp
activ
secretas
sheddas
proteas
releas
solubl
form
transmembran
protein
peptid
eg
cellsurfac
receptor
membran
anchor
cytokin
chemokin
membran
proteas
amyloid
precursor
protein
belong
group
adam
disintegrin
metalloproteinas
adam
may
cleav
releas
cellsurfac
peptidas
yield
solubl
form
sinc
mtmmp
adam
act
larger
protein
belong
either
broader
group
secret
proteas
mmp
repres
distinct
group
oligo
peptidas
exclud
review
reader
refer
special
review
inform
itoh
nagas
moss
lambert
viss
nagas
zucker
chen
interestingli
mani
cellsurfac
oligo
peptidasesthough
special
short
peptidesbelong
famili
protein
broader
spectrum
activ
peptidas
regulatori
peptid
also
proteas
larger
protein
eg
extracellular
matrix
protein
proteoglycan
even
bind
protein
molecul
without
proteolyt
activ
therefor
surpris
cellsurfac
peptidas
may
multipl
function
regulatori
peptidas
extracellular
proteas
bind
protein
divers
function
discuss
review
term
cellsurfac
peptidas
dipeptidylpeptidas
iv
member
famili
sinc
cellsurfac
peptidas
actual
pharmacolog
import
today
properti
structur
distribut
physiolog
pharmacolog
import
cellsurfac
peptidas
well
describ
less
known
role
cell
biolog
exampl
cellsurfac
peptidas
multimer
enzym
rare
explor
whether
form
heterom
anoth
member
gene
famili
result
function
also
rel
littl
known
dynam
peptidas
cell
surfac
associ
proteas
receptor
transport
bind
protein
fate
endocytot
process
review
provid
gener
overview
cellsurfac
oligo
peptidas
tabl
particular
nomenclatur
structur
cell
anchor
physiolog
pharmacolog
import
properti
discuss
term
select
surfac
peptidas
actual
pharmacolog
interest
enzym
hydrolyz
peptid
bond
commonli
term
proteas
proteinas
peptidas
proteolyt
enzym
histor
term
slightli
diver
mean
name
peptidas
act
small
peptid
proteas
degrad
larger
protein
proteinas
endopeptidas
cleav
peptid
chain
intern
barrett
mcdonald
mcdonald
barrett
term
often
use
synonym
enzym
nomenclatur
ec
list
http
wwwchemqmwacukiubmbenzym
indexhtml
recommend
term
peptidas
gener
form
term
cellsurfac
peptidas
use
former
sens
proteolyt
enzym
act
small
peptid
oligopeptidas
locat
cell
surfac
extracellular
activ
site
gener
term
ectoenzym
use
exopeptidas
cleav
one
residu
cterminu
peptid
wherea
endopeptidas
formerli
ident
proteinas
act
intern
peptid
chain
aminopeptidas
liber
either
singl
amino
acid
residu
nterminu
aminopeptidas
ec
dipeptid
tripeptid
nterminu
dipeptidylpeptidas
tripeptidylpeptidas
ec
cleav
singl
residu
cterminu
term
carboxypeptidas
liber
dipeptid
term
peptidylpeptidas
ec
exopeptidas
specif
dipeptid
dipeptidas
ec
remov
termin
residu
substitut
cycliz
link
isopeptid
bond
peptid
linkag
amino
acid
side
chain
later
term
omega
peptidas
ec
term
oligopeptidas
also
use
endopeptidas
act
optim
smaller
peptid
protein
cellsurfac
peptidas
act
small
peptid
belong
group
endopeptidas
exopeptidas
special
peptidas
act
larger
protein
endopeptidas
proteas
classifi
accord
catalyt
center
serin
cystein
aspart
metalloproteas
barrett
cellsurfac
peptidas
either
serin
often
metalloproteas
base
molecular
structur
evolutionari
relationship
divid
famili
clan
system
explain
detail
barrett
et
al
use
merop
databas
http
meropssangeracuk
databas
give
excel
precis
detail
inform
proteas
mani
speci
scheme
famili
peptidas
group
member
show
statist
signific
relationship
amino
acid
sequenc
least
anoth
member
famili
term
clan
use
describ
group
famili
member
evolv
singl
ancestr
protein
diverg
far
relationship
prove
direct
comparison
primari
structur
apart
excel
merop
databas
http
meropssangeracuk
inform
protein
structur
proteas
obtain
swissprot
protein
sequenc
databas
http
wwwexpasych
especi
enzym
http
wwwexpasyorgenzym
pir
databas
http
pirgeorgetownedu
genet
inform
obtain
http
wwwncbinlmnihgov
http
bioinformaticsweizmannacilcard
http
catalyt
properti
proteas
compli
brenda
enzym
inform
system
http
brendabcunikoelnd
inform
especi
anim
given
http
delphiphysunivtoursfrprolysi
excel
print
compil
proteas
given
handbook
proteolyt
enzym
barrett
et
al
older
refer
compil
barrett
mcdonald
mcdonald
barrett
kenni
kenni
hooper
kenni
et
al
still
valuabl
sourc
contrast
intracellular
extracellular
secret
proteas
cellsurfac
peptidas
anchor
plasma
membran
nearli
exclus
integr
membran
protein
exampl
solubl
secret
proteas
also
bound
cell
surfac
via
receptor
exampl
secret
solubl
urokinas
urokinasetyp
plasminogen
activ
ec
proteas
involv
activ
proteas
blotclot
lysi
cell
invas
bound
cell
surfac
via
specif
membran
receptor
integr
membran
protein
cellsurfac
peptidas
either
possess
transmembran
region
n
type
cterminu
type
ii
extracellular
link
membran
via
glycosylphosphatidylinositol
gpi
anchor
fig
cellsurfac
protein
glycoprotein
high
degre
eg
molecular
mass
carbohydr
found
extracellular
site
cellsurfac
peptidas
also
exist
solubl
form
solubl
form
appar
gener
proteolyt
shed
cell
surfac
fig
rather
diver
splice
form
far
condit
shed
secretas
involv
rare
investig
except
angiotensinconvert
enzym
ace
ec
solubl
form
known
liber
member
adam
famili
hooper
et
al
parkin
et
al
solubl
ace
solubl
form
cellsurfac
peptidas
present
normal
physiolog
condit
blood
plasma
amniot
fluid
semin
plasma
bodi
fluid
level
solubl
ace
alter
certain
diseas
sarcidosi
diabet
mellitu
gaucher
diseas
leprosi
hyperthyroid
howev
solubl
equival
cellsurfac
peptidas
also
exist
encod
diver
gene
aminopeptidas
p
app
xpro
aminopeptidas
ec
two
form
membranebound
form
encod
gene
human
x
chromosom
sprinkl
et
al
cytosol
form
encod
gene
human
chromosom
sprinkl
et
al
nearli
ident
substrat
specif
membranebound
form
fig
topolog
cellsurfac
peptidas
cellsurfac
peptidas
anchor
plasma
membran
either
transmembran
region
schemat
lipid
bilay
helic
lipophil
amino
acid
sequenc
type
nterminu
extracellular
type
ii
cterminu
extracellular
link
membran
via
glycosylphosphatidylinositol
gpi
anchor
extracellular
region
highli
glycosyl
schemat
hexos
secretas
may
liber
extracellular
part
cellsurfac
peptidas
yield
solubl
variant
locat
ectoenzym
via
glycosylphosphatidylinositol
anchor
plasma
membran
endotheli
epitheli
cell
wherea
solubl
form
cytosol
enzym
found
leukocyt
platelet
brain
harbeck
mentlein
hooper
et
al
simmon
orawski
cytosol
form
display
amino
acid
ident
similar
membranebound
cottrel
et
al
classifi
member
peptidas
clan
mg
basi
sequenc
structur
similar
hyde
et
al
exopeptidas
includ
solubl
peptidas
methionyl
aminopeptidas
type
ii
ec
xpro
dipeptidas
prolidas
ec
sinc
cellsurfac
peptidas
act
extracellular
regulatori
peptid
activ
catalyt
site
locat
larg
extracellular
domain
therefor
cell
surfac
peptidas
also
term
ectopeptidas
accord
catalyt
type
cellsurfac
peptidas
possess
either
catalyt
triad
asp
ser
serin
peptidas
metallobind
motif
dival
cation
normal
zinc
metalloproteas
known
metal
ligand
metalloproteas
glu
asp
ly
addit
metal
ligand
least
one
residu
requir
catalysi
mostli
glu
also
arg
ly
normal
catalyt
site
found
one
catalyt
center
eg
angiotensinconvert
enzym
ec
two
catalyt
hexxh
metalloproteas
motif
barrett
et
al
hooper
threedimension
structur
cellsurfac
peptidas
metalloand
serin
peptidas
clarifi
exampl
pharmacolog
import
reader
refer
origin
special
review
articl
engel
et
al
lowther
matthew
natesh
et
al
rasmussen
et
al
specif
cleavag
peptid
bond
cellsurfac
peptidas
describ
terminolog
berger
schechter
residu
peptid
substrat
number
accord
nterminu
p
p
p
p
p
p
cterminu
mark
cleavag
site
cellsurfac
peptidas
show
except
high
cleavag
select
eg
app
liber
p
residu
nterminu
peptid
prolin
p
posit
other
show
much
broader
select
michaelismenten
kinet
enzym
normal
character
k
v
max
respect
k
cat
v
max
mol
enzym
valu
howev
k
valu
oligopeptidas
micomolar
rang
wherea
physiolog
concentr
regulatori
peptid
hormon
neuropeptid
cytokin
nanomolar
picomolar
rang
k
valu
receptor
low
concentr
substrat
comparison
k
valu
reaction
rate
enzym
e
given
v
k
cat
k
ie
linear
curv
depend
v
fersht
therefor
rate
specif
constant
k
cat
k
best
basi
compar
potenc
peptidas
di
verent
peptid
physiolog
concentr
high
rate
constant
correspond
high
cleavag
rate
low
physiolog
concentr
certain
cellsurfac
molecul
includ
cellsurfac
peptidas
identifi
immun
cell
use
monoclon
antibodi
initi
without
know
broader
tissu
distribut
base
di
verenti
monoclon
antibodi
cluster
di
verenti
cd
antigen
defin
later
shown
ident
wellstudi
cellsurfac
peptidas
tabl
ii
exampl
origin
describ
calla
common
acut
lymphoblast
leukemia
antigen
associ
acut
lymphoblast
leukemia
use
diagnosi
identifi
later
alreadi
known
neutral
endopeptidas
neprilysin
enkephalinas
ec
inform
cd
antigen
nomenclatur
distribut
function
found
http
wwwncbinlmnihgovprow
initi
cellsurfac
proteas
isol
kidney
intestin
brush
border
membran
rich
sourc
membranebound
proteas
kenni
kenni
et
al
locat
point
physiolog
role
final
degrad
peptid
peptid
fragment
produc
proteas
fact
cellsurfac
proteas
act
mostli
substrat
less
amino
acid
residu
exhibit
broader
substrat
specif
tabl
iii
therefor
anticip
cellsurfac
peptidas
intestin
lumin
surfac
involv
digest
nutrit
protein
digest
role
shown
cellsurfac
proteas
broad
specif
aminopeptidas
n
well
prolinespecif
peptidas
dipeptidylpeptidas
iv
carboxypeptidas
p
brandsch
et
al
erickson
et
al
heymann
mentlein
yoshioka
et
al
sinc
peptid
bond
involv
prolin
residu
resist
attack
nonspecif
proteas
trpysin
chymotrypsin
aminopeptidas
carboxypeptidas
prolinespecif
exopeptidas
appear
necessari
final
digest
peptid
howev
far
knockout
defici
anim
show
clinic
abnorm
protein
digest
see
tabl
iv
howev
case
probabl
human
aminopeptidas
p
defici
show
peptidurea
xaapropeptid
blau
et
al
later
cellsurfac
peptidas
narrow
specif
pyroglutamylpeptidas
ii
endothelinconvert
enzym
detect
furthermor
discov
cellsurfac
peptidas
act
regulatori
peptid
even
intestin
locat
turn
locat
discret
site
contact
endogen
hormon
neuropeptid
consequ
degrad
bioactiv
peptid
cellular
bind
function
regard
main
function
cellsurfac
peptidas
proteolyt
process
involv
inactiv
partial
inactiv
activ
regulatori
peptid
hormon
neuropeptid
cytokineschemokin
activ
intracellular
store
peptid
normal
accomplish
signal
peptidas
prohormon
convertas
within
secretori
vesicl
extracellular
proteolyt
activ
occur
secret
hormon
eg
angiotensinogenangiotensin
convers
membranebound
form
activ
solubl
form
eg
tumor
necrosi
factora
fractalkin
wherea
later
case
solubl
form
gener
mostli
member
adam
famili
integr
membran
proform
secret
prohormon
cleav
cellsurfac
proteas
shed
solubl
form
proteas
broader
specif
activ
regulatori
peptid
cellsurfac
proteas
promin
exampl
ace
activ
angiotensin
potent
vasopressor
octapeptid
angiotensin
ii
releas
ctermin
dipeptid
endothelinconvert
enzym
ece
cleav
big
endothelin
endothelin
tabl
iii
wherea
ace
display
rel
broad
specif
addit
angiotensin
bradykinin
neurotensin
substanc
p
gonadoliberin
also
cleav
implic
blood
pressur
regul
well
rang
biolog
process
immun
reproduct
neuropeptid
regul
ece
specif
enzym
activ
inact
big
endothelin
activ
vasoconstrictor
endothelin
consequ
inhibitor
ace
ece
reduc
format
activ
hypertens
hormon
angiotensin
ii
endothelin
therefor
use
antihypertens
drug
detail
ace
ece
see
barrett
et
al
merpo
databas
http
meropssangeracuk
partial
inactivationactiv
process
regulatori
peptid
process
truncat
form
retain
physiolog
activ
one
receptor
subtyp
creat
activ
new
one
sinc
diverenti
inactiv
often
depend
ctermin
residu
exopeptidas
mostli
involv
process
detail
exampl
discuss
peptid
truncat
dipeptidylpeptidas
iv
dpp
iv
similar
partial
inactiv
regulatori
peptid
also
observ
aminopeptidas
p
carboxypeptidas
bradykinin
aminopeptidas
form
angiotensin
iii
sometim
truncat
peptid
still
bind
receptor
transduc
signal
target
cell
consequ
cellsurfac
peptidas
gener
antagonist
ayniti
normal
less
equal
nativ
peptid
therefor
doubt
product
antagonist
high
physiolog
relev
vivo
howev
proteolyt
gener
antagonist
downregul
surfac
express
receptor
crucial
import
receptor
high
intern
rate
eg
chemokin
receptor
cell
surfac
peptidas
dpp
iv
see
creat
antagonist
reduc
ayniti
still
import
receptor
regul
properti
ludwig
et
al
inactiv
regulatori
peptid
regard
main
physiolog
function
cellsurfac
peptidas
role
concern
peptid
hormon
circul
blood
stream
paracrineautocrin
hormon
tissu
neuropeptid
brain
peripher
site
inactiv
necessari
event
regul
signal
transmiss
otherwis
perman
stimuli
would
result
halfliv
signal
molecul
extracellular
commun
diver
consider
millisecond
second
classic
neurotransmitt
acetylcholin
amino
acid
catecholamin
second
minut
neuropeptid
peptid
hormon
minut
hour
even
day
growth
factor
cytokin
proteolyt
degrad
chemic
modif
peptid
oxid
conjug
reaction
occur
rare
exampl
question
physiolog
relev
inactiv
mechan
elimin
divus
filtrat
also
import
highayn
cellular
uptak
peptid
observ
exampl
peptid
hormon
glucagonlik
see
circul
blood
min
postprandi
releas
intestin
time
remov
filtrat
urin
kidney
howev
inactiv
proteolyt
truncat
case
dpp
iv
see
consider
reduc
activ
form
physiolog
activ
insulin
releas
consequ
cellsurfac
peptidas
inhibitor
potenti
drug
prolong
activ
endogen
regulatori
peptid
case
activ
hinder
gener
tabl
iii
list
import
physiolog
substrat
cellsurfac
peptidas
common
peptidas
restrict
peptid
substrat
residu
therefor
term
oligopeptidas
adequ
exhibit
rather
broad
specif
eg
aminopeptidas
n
apn
neprilysin
nep
other
restrict
certain
type
bond
cleav
eg
app
dpp
iv
still
other
substrat
specif
name
pyroglutamylpeptidas
ii
strictli
ece
certain
regulatori
peptid
cleav
diver
cellsurfac
peptidas
eg
substanc
p
bradykinin
enkephalin
depend
tissuecellular
environ
cellsurfac
proteas
crucial
import
method
determin
degrad
regulatori
peptid
often
includ
cell
cultur
system
purifi
system
degrad
monitor
highperform
liquid
chromatographi
hplc
reversedphas
separ
column
use
gradient
acetonitril
trifluoroacet
acid
capillari
electrophoresi
mass
spectroscopi
mentlein
luciu
interestingli
although
peptidas
may
cleav
varieti
peptid
inhibitor
target
mainli
one
system
certain
diseas
inhibitor
ace
inhibit
angiotensin
ii
format
ece
inhibit
endothelin
format
nep
prolong
action
atrial
natriuret
peptid
use
reduc
blood
pressur
dpp
iv
inhibitor
prolong
action
see
develop
treatment
type
diabet
target
ace
nep
dpp
iv
also
cleav
variou
regulatori
peptid
follow
section
contain
gener
overview
diver
cellsurfac
peptidas
role
inactiv
activ
regulatori
peptid
restrict
import
exampl
one
exampl
actual
pharmacolog
import
dpp
iv
detail
descript
given
end
summar
divers
function
regulatori
proteas
also
provid
inform
member
protein
famili
illustr
addit
nonproteolyt
function
cellsurfac
peptidas
aminopeptidas
n
attack
varieti
substrat
residu
although
hydrophob
neutral
residu
prefer
enkephalin
dynorphin
appear
import
substrat
note
truncat
regulatori
peptid
eg
somatostatin
inactiv
enzym
homodim
highli
glycosyl
type
ii
integr
membran
kda
subunit
found
brush
border
membran
kidney
intestin
mucos
cell
liver
import
local
catabol
regulatori
peptid
endotheli
cell
apic
domain
smooth
muscl
cell
monocytesmacrophag
relat
cell
eg
microgli
cell
granulocyt
barrett
et
al
luciu
et
al
mentlein
roo
mizutani
et
al
safavi
hersh
aminopeptidas
truncat
angiotensin
ii
brain
angiotensin
iii
exert
tonic
stimulatori
action
central
control
blood
pressur
thu
central
inhibitor
apa
constitut
put
central
antihypertens
agent
apa
express
mani
tissu
among
hematopoiet
cell
b
cell
stage
lineag
diverenti
stage
specif
antigen
respect
angiotensin
ii
catabol
endotheli
cell
import
local
bausback
et
al
barrett
et
al
mentlein
roo
rozenfeld
et
al
aminopeptidas
p
cell
surfac
form
term
aminopeptidas
distinguish
solubl
form
code
diver
relat
gene
see
liber
ntermin
arg
bradykinin
follow
propro
residu
may
liber
dpp
iv
orawski
et
al
app
anchor
via
gpi
anchor
cell
surfac
inactiv
bradykinin
appear
import
lung
especi
rodent
high
app
activ
observ
prechel
et
al
inactiv
neuropeptid
appear
less
import
mentlein
et
al
orawski
simmon
interestingli
ace
inhibitor
also
inhibit
app
hooper
et
al
kim
et
al
evect
may
addit
respons
side
evect
ace
inhibitor
membranebound
app
found
kidney
small
intestin
brush
border
membran
endotheli
lymphoid
cell
barrett
et
al
one
report
probabl
human
app
defici
show
peptiduria
xaapro
peptid
clincal
symptom
blau
et
al
pyroglutamylpeptidas
ii
strict
substratespecif
enzym
liber
termin
pyroglutam
acid
thyrotropinreleas
hormon
trh
pyroglutaminyl
peptid
gonadoliberin
neurotensin
attack
bauer
bauer
enzym
found
particular
brain
neuron
anterior
pituitari
mammotrop
retina
lung
liver
bauer
et
al
also
solubl
serum
obvious
shed
form
exist
schmitmeier
et
al
extraordinarili
high
degre
substrat
specif
restrict
local
indic
pyroglutamylpeptidas
ii
special
function
inactiv
enzym
trh
neurotransmitt
brain
hypothalam
releas
hormon
circul
bauer
schomburg
et
al
dipeptidylpeptidas
iv
physiolog
role
discuss
detail
carboxypeptidas
cpm
cleav
basic
amino
acid
arg
ly
varieti
peptid
substrat
bradykinin
dynorphin
appear
natur
substrat
wide
distribut
enzym
anchor
cell
surfac
gpi
anchor
highest
level
found
lung
placenta
kidney
intestin
blood
vessel
brain
peripher
nerv
hematopoiet
cell
cpm
found
discret
b
lymphocyt
development
stage
matur
mostli
activ
cell
de
saintvi
et
al
also
solubl
form
exist
variou
bodi
fluid
cpm
suppos
inactiv
bradykinin
partial
cpmtruncat
bradykinin
inact
receptor
bind
receptor
furthermor
cpm
remov
ctermin
arg
human
anaphylatoxin
abolish
spasmogen
histaminereleas
activ
wherea
chemotact
activ
retain
also
sever
growth
factor
epiderm
growth
factor
hepatocyt
growth
factor
erythropoietin
brainderiv
neurotroph
factor
vascular
endotheli
growth
factor
oncostatin
other
truncat
cpm
physiolog
import
remain
establish
barrett
et
al
mentlein
roo
skidgel
carboxypeptidas
p
liber
ctermin
amino
acid
peptid
penultim
pro
far
role
intestin
digest
prolinecontain
peptidesfrag
recogn
although
regulatori
peptid
angiotensin
ii
enterostatin
also
identifi
substrat
kenni
mentlein
roo
yoshioka
et
al
angiotensinconvert
enzym
ace
liber
dipeptid
small
peptid
provid
ultim
penultim
residu
aspglu
pro
main
physiolog
substrat
angiotensin
bradykinin
howev
substrat
specif
rel
broad
enkephalin
dynorphin
neurotensin
also
cleav
furthermor
ace
also
display
endopeptidas
activ
toward
dynorphin
substanc
p
gonadoliberin
ace
exist
two
isoform
somat
form
kda
endotheli
epitheli
neuron
cell
smaller
isoform
kda
germin
cell
furthermor
solubl
shed
form
exist
base
convers
angiotensin
activ
angiotensin
ii
ace
control
blood
pressur
salt
metabol
regard
main
physiolog
role
consequ
highli
specif
ace
inhibitor
develop
wide
use
antihypertens
drug
main
side
evect
ace
inhibitor
attribut
prolong
lifetimeevect
bradykinin
howev
ace
may
also
anoth
function
regulatori
peptidas
especi
brain
detail
wellinvestig
cellsurfac
peptidas
physiolog
pharmacolog
import
reader
refer
detail
review
barrett
et
al
corvol
et
al
menard
patchett
skidgel
et
al
addit
long
known
ace
similar
cellsurfac
enzym
recent
discov
angiotensinconvert
aceh
also
convert
angiotensin
angiotensin
ii
bradykinin
inhibit
lisinopril
captopril
organand
cellspecif
express
uniqu
cleavag
key
vasoact
peptid
suggest
essenti
role
local
reninangiotensin
system
heart
kidney
danilczyk
et
al
turner
et
al
membran
dipeptidas
mbd
gpianchor
enzym
variou
tissu
eg
kidney
lung
act
dipeptid
peptidyl
leucotrien
blactam
antibiot
kidney
implic
metabol
glutathion
remov
glutam
residu
gglutamyl
transpeptidas
lung
convert
peptidyl
leukotrien
major
compon
slowreact
substanc
anaphylaxi
bronchoand
vasocontrictor
inact
leukotrien
e
furthermor
blactam
antibiot
cleav
inactiv
barrett
et
al
recent
addit
member
dipeptidas
famili
identifi
habib
et
al
neprilysin
neutral
endopeptidas
nep
preferenti
cleav
peptid
bond
bulki
hydrophob
residu
p
posit
endopeptidas
substrat
also
display
peptidyldipeptidas
charact
enkephalin
dynorphin
peptid
residu
cleav
although
e
ycienci
hydrolysi
declin
peptid
length
princip
substrat
enkephalin
atrial
natriuret
peptid
substanc
p
tachykinin
variou
regulatori
peptid
eg
somatostatin
neurokinin
bradykinin
gastrinreleas
peptid
calcitonin
calcitonin
generel
peptid
chemotact
bacteri
peptid
fmetleuph
cleav
kenni
kenni
hooper
recent
discov
target
amyloid
bpeptid
whose
accumul
caus
alzheim
diseas
brain
shirotani
et
al
endopeptidas
wide
distribut
variou
tissu
eg
kidney
intestin
placent
brush
border
membran
immun
cell
choroid
plexu
neuron
brain
schwann
cell
thu
nep
inhibitor
may
potenti
treatment
hypertens
alreadi
use
clinic
trial
pain
inflamm
detail
inform
reader
refer
special
review
barrett
et
al
merpo
databas
http
meropssangeracuk
endothelinconvert
enzym
structur
relat
nep
physiolog
involv
activ
endothelin
potent
vasconstrictor
gener
intermedi
proform
big
endothelin
big
endothelin
biolog
inact
amino
acid
residu
intermedi
gener
endothelin
peptid
precursor
approxim
residu
prohormon
process
enzym
furin
secretori
vesicl
activ
big
endothelin
activ
vasoconstrictor
accomplish
cleavag
bond
ece
shown
locat
either
cell
surfac
golgi
depend
tissu
relat
appear
golgi
protein
therefor
strict
sens
cellsurfac
proteas
see
consequ
enzym
potenti
drug
target
treatment
hypertens
barrett
et
al
b
role
cellsurfac
peptidas
csp
cellsurfac
peptidas
rather
larg
highli
glycosyl
protein
compar
simpl
proteas
trypsin
molecular
mass
kda
huge
portion
peptid
chain
appear
necessari
enzymat
activ
therefor
surpris
extracellular
domain
cellsurfac
peptidas
fulfil
function
bind
protein
receptor
fact
certain
cellsurfac
peptidas
structur
homologu
without
peptidas
activ
exist
appear
bind
function
dpp
iv
excel
exampl
cellsurfac
peptidas
dual
function
enzym
bind
protein
see
human
dpp
iv
act
bind
molecul
adenosin
deaminas
import
enzym
cellular
humor
immun
well
extracellular
matrix
substanc
furthermor
dpp
iv
belong
gene
famili
protein
special
peptidas
function
dpp
iv
bind
function
transmembran
structur
similar
dpp
iv
suppos
arisen
gene
duplic
lack
peptidas
activ
appear
bind
protein
detail
given
specif
express
cellsurfac
peptidas
might
also
contribut
special
certain
tissu
special
breast
vasculatur
attribut
express
app
tissu
essler
ruoslahti
app
abl
bind
certain
synthet
peptid
sequenc
mimic
structur
cancer
cell
respons
metastasi
distinct
tissu
virus
use
cellsurfac
molecul
infect
endocytosi
apart
receptor
carbohydr
peptidas
also
might
serv
function
fact
apn
act
receptor
coronaviru
infect
epitheli
cell
respiratori
tract
mediat
human
cytomegaloviru
infect
respons
herp
enhanc
bind
surfac
infect
cell
delma
et
al
summari
main
function
cellsurfac
peptidas
appear
enzymat
activ
may
addit
bind
activ
structur
homologu
evolv
special
function
less
like
vice
versa
cell
surfac
may
evolv
cellsurfacebind
protein
furthermor
plasma
membran
protein
function
bindingentri
virus
home
cellscanc
cell
intracellular
sequenc
cellsurfac
peptidas
normal
short
less
amino
acid
contain
obviou
motif
therefor
direct
signal
transduct
evect
without
associ
function
molecul
expect
howev
connect
receptor
cellmembraneassoci
enzym
signal
transduc
evect
observ
particular
apn
dpp
iv
gglutamyl
transpeptidas
ggt
induct
signal
may
trigger
inhibitor
substrat
bind
protein
inhibit
either
apn
gene
express
apn
enzymat
activ
profound
evect
prolifer
function
cell
lendeckel
et
al
promin
chang
observ
applic
inhibitor
actinonin
probestin
includ
activ
mitogenactiv
protein
kinas
mapk
erk
extracellularregul
kinas
wnt
pathway
decreas
product
proinflammatori
cytokin
induct
immunosuppress
cytokin
transform
growth
factorb
tgfb
howev
precis
mechan
whether
direct
indirect
remain
specul
dpp
iv
regard
costimul
cell
et
al
associ
antigen
bind
protein
especi
adenosin
deaminas
extracellular
matrix
protein
inhibitor
induc
cytokin
product
prolifer
protein
tyrosin
phosphatas
well
mapk
appear
involv
process
see
detail
sinc
ggt
key
enzym
homeostasi
reduc
glutathion
gsh
implic
regul
cellular
redox
state
furthermor
b
cell
ggt
associ
member
tetraspan
famili
includ
nichol
et
al
remain
unclear
whether
antigen
activ
modul
oxid
signal
could
respons
observ
evect
intracellular
signal
transduct
system
paolicchi
et
al
taken
togeth
signal
transduct
evect
cellsurfac
peptidas
report
despit
short
cytoplasm
domain
antczak
et
al
appear
howev
evect
result
mainli
associ
cellsurfac
molecul
cellsurfac
peptidas
might
implic
cell
invas
possibl
abil
adher
extracellular
matrix
protein
degrad
induc
gene
involv
process
present
experiment
evid
role
cellsurfac
peptidas
especi
dpp
iv
apn
exact
mechan
remain
uncertain
atherton
et
al
shingu
et
al
dpp
iv
shown
bind
collagen
iii
see
furthermor
close
structur
homologu
dpp
iv
devoid
enzymat
activ
appear
act
bind
protein
see
far
function
cellsurfac
peptidas
inact
homologu
cell
invas
tissu
integr
rel
unexplor
interest
emerg
field
research
mani
investig
conduct
aberr
express
cellsurfac
peptidas
variou
diseas
distinguish
whether
activ
solubl
form
bodi
fluid
measur
whether
express
membranebound
form
determin
activ
measur
enzymeimmunohistochem
strain
flow
cytometr
fac
analysi
solubl
activ
studi
hamper
littl
knowledg
shed
cell
surfac
regul
membranebound
form
littl
known
induct
growth
factor
correspond
transcript
element
often
tissuecelltyp
specif
aspect
cover
two
recent
review
antczak
et
al
b
gener
high
express
bodi
fluid
cell
surfac
correl
hyperplasia
tissu
normal
express
cellsurfac
peptidas
eg
cancer
chronic
inflammatori
diseas
cellsurfac
peptidas
also
excel
marker
tissu
diverenti
especi
express
hematopoiet
cell
see
cellsurfac
peptidas
cd
nomenclatur
therefor
use
monitor
process
identifi
neoplast
transform
particular
leukemia
lymphoma
also
cell
activ
sometim
detect
elev
express
see
previou
exampl
although
precis
regul
growth
factorscytokin
development
program
less
known
today
also
littl
knowledg
whether
tissuedepend
regul
express
consequ
peptidas
activ
influenc
main
physiolog
function
name
inactiv
regulatori
peptid
although
caution
exercis
extrapol
result
animalmic
model
human
target
inactiv
inherit
defect
gene
cellsurfac
peptidas
provid
import
hint
concern
physiolog
function
tabl
iv
wherea
exampl
ace
abnorm
directli
evid
exampl
investig
far
defect
physiolog
advantag
visibl
certain
experiment
condit
point
nonredund
intrins
role
certain
surfac
peptidas
wherea
other
import
certain
environment
stressor
situat
redund
gene
nevertheless
nep
dpp
iv
knockout
micedefect
rat
demonstr
enzym
function
regulatori
peptidas
vitro
import
regul
neuropeptid
peptid
hormon
also
vivo
interestingli
besid
main
function
also
appear
particip
complic
diseas
tumor
metastasi
alzheim
diseas
interestingli
human
defici
mutat
cellsurfac
peptidas
gene
well
explor
rare
clear
document
exampl
app
blau
et
al
howev
increas
inform
genet
variat
certainli
reveal
role
suscept
diseas
gene
anticip
particular
gene
cellsurfac
peptidas
inhibitor
use
drug
dipeptidyl
amino
peptidas
dpp
ec
liber
dipeptid
nterminu
peptid
except
dpp
iv
lysosom
cytosol
proteas
two
type
specif
distinguish
dpp
rel
broad
specif
dpp
lysosom
cysproteas
dpp
iii
cytosol
metalloproteas
restrict
prolin
second
ntermin
penultim
posit
ddp
complementari
specif
dpp
ii
dpp
iv
liber
xaapro
xaaala
dipeptid
nterminu
gener
dpp
act
mainli
short
medium
chain
peptid
residu
less
larger
protein
type
dpp
could
regard
mere
digest
regulatori
proteas
digest
enzym
involv
final
degrad
peptid
either
intraor
extracellularli
regulatori
enzym
activ
inactiv
bioactiv
peptid
sinc
extracellular
commun
molecul
cellsurfac
dipeptidyl
peptidas
iv
dpp
iv
physiolog
import
recent
year
dpp
iv
attract
consider
interest
drug
target
particular
treatment
type
diabet
therefor
enzym
describ
detail
exampl
import
cellsurfac
peptidas
gorrel
et
al
et
al
mentlein
mentlein
despit
surfac
oligopeptidas
brief
inform
given
dpp
ivrel
molecul
human
dpp
iv
dimer
glycoprotein
compos
two
subunit
tabl
v
mrna
code
type
ii
integr
membran
protein
amino
acid
anchor
plasma
membran
amino
residu
hydrophob
membranespan
domain
vllg
llgaaalvti
itvpvvll
preced
short
intracellular
hydrophil
sequenc
mktpwk
nterminu
extracellular
sequenc
contain
nine
potenti
nlink
glycosyl
site
due
presenc
sialic
acid
carbohydr
structur
dpp
iv
acid
isoelectr
point
rat
sequenc
exhibit
ident
human
sequenc
lack
one
residu
one
glycosyl
site
ctermin
region
residu
human
rat
sequenc
complet
conserv
crystal
structur
dpp
iv
homodim
publish
recent
engel
et
al
rasmussen
et
al
subunit
consist
two
domain
abhydrolas
domain
eightblad
bpropel
domain
two
domain
larg
caviti
found
access
via
tow
open
substrat
product
pass
either
funnel
center
propel
domain
much
larger
open
side
domain
human
dpp
iv
gene
locat
long
arm
chromosom
span
approxim
kb
contain
exon
rang
size
bp
kb
abbott
et
al
flank
domain
contain
neither
tata
box
caat
box
region
extrem
rich
c
g
potenti
bind
site
sever
transcript
factor
nfkb
tabl
v
abbott
et
al
hm
et
al
dpp
iv
gene
encod
two
mrna
size
kb
express
diver
rel
rate
individu
tissu
dpp
iv
wide
tissu
distribut
found
mani
epitheli
certain
special
mesoderm
cell
tabl
v
often
present
site
physiolog
border
eg
bloodbrain
barrier
import
intestin
epitheli
cell
fig
electron
microscopi
clearli
show
presenc
cell
surfac
littl
known
dynam
dpp
iv
plasma
membran
intracellular
vesicl
endocytot
process
fig
appear
dpp
iv
associ
glycolipidand
cholesterolrich
membran
microdomain
known
raft
rather
coat
pit
riemann
et
al
fig
addit
membranebound
form
solubl
dpp
iv
exist
transmembran
domain
human
serum
dpp
iv
lack
first
residu
durinx
et
al
iwakiegawa
et
al
plasma
form
lack
first
residu
durinx
et
al
ohkubo
et
al
solubl
form
consid
produc
proteolyt
shed
cell
surfac
endotheli
epitheli
cell
howev
proteas
respons
releas
condit
activ
process
yet
identifi
dpp
iv
discov
enzym
liber
naphthylamin
initi
term
glycylprolin
naphthylamidas
hopsuhavu
glenner
fact
mammalian
dpp
iv
exhibit
restrict
substrat
specif
fig
p
posit
prolin
alanin
accept
almost
exclus
peptid
chromogen
substrat
pro
better
hydrolyz
correspond
one
ala
howev
import
natur
peptid
substrat
penultim
pro
ala
tabl
vi
apart
peptid
small
p
residu
eg
ser
val
gli
leu
cleav
although
consider
lower
rate
eg
glucagon
hink
et
al
martin
et
al
pospisilik
et
al
analogu
growth
hormonereleas
hormon
grh
bonger
et
al
macrophagederiv
chemokin
mdc
glypro
tyrgli
sequenti
releas
proost
et
al
p
posit
unsubstitu
proteinogen
amino
acid
accept
includ
prolin
substrat
hydrophob
basic
residu
better
fig
schemat
represent
substrat
cleav
dpp
iv
dipeptid
liber
nterminu
peptid
pro
ala
p
posit
certain
peptid
small
amino
acid
p
posit
cleav
low
rate
p
posit
bulki
hydrophob
basic
amino
acid
oblig
free
amino
group
prefer
peptid
pro
hyp
p
posit
resist
dpp
iv
hydrolyz
acid
one
peptid
bond
p
p
residu
must
tran
posit
peptid
pro
hyp
p
posit
cleav
eg
bradykinin
argpropro
chain
length
peptid
substrat
systemat
investig
peptid
residu
degrad
sequestr
larger
protein
may
depend
tertiari
structur
nausch
et
al
restrict
explain
threedimension
structur
dpp
iv
rasmussen
et
al
optim
cleavag
rate
gener
observ
ph
valu
apart
action
strict
exopeptidas
endopeptidas
activ
collagen
extracellular
matrix
protein
postul
occasion
dpp
iv
bermpohl
et
al
present
howev
exclud
endopeptidas
activ
result
proteas
close
relat
associ
dpp
iv
eg
fibroblast
activ
protein
sepras
form
heterodim
dpp
iv
dpp
iv
belong
serin
class
proteas
clan
sc
famili
compar
barrett
et
al
http
meropssangeracuk
catalyt
triad
invertedli
arrang
compar
trypsinlik
serin
proteas
hisasps
therefor
dpp
iv
classifi
nonclass
serin
proteas
activ
site
sequenc
gwsyg
around
catalyt
serin
residu
david
et
al
ogata
et
al
correspond
consensu
sequenc
gxsxg
serin
proteas
found
one
copi
posit
human
sequenc
singl
substitut
sequenc
substrain
rat
g
r
activ
site
gwsyr
result
loss
enzymat
activ
due
defici
activ
dpp
iv
rat
strain
becom
valuabl
model
studi
physiolog
function
fujiwara
et
al
watanab
et
al
accord
catalyt
structur
dpp
iv
inhibit
less
power
serin
enzym
inhibitor
coval
modifi
activ
site
diisopropylfluorophosph
good
inhibitor
wherea
phenylmethylsulfonylfluorid
rel
inevect
mcdonald
barrett
et
al
metal
ion
pb
hg
zn
strongli
inhibitori
inhibitor
class
proteas
inhibitor
aminopeptidas
eg
bestatin
inevect
specif
dpp
iv
inhibitor
act
low
concentr
special
interest
physiolog
investig
potenti
clinic
applic
microbi
peptid
diprotin
ileproil
diprotin
b
valproleu
competit
substrat
slowli
hydrolyz
act
select
competit
inhibitor
dpp
iv
micromolar
concentr
rahfeld
et
al
addit
sever
type
substrat
analogu
synthes
power
specif
inhibitor
micromolar
picomolar
concentr
eg
prolin
boron
acid
dipeptid
inhibitor
revers
dipeptid
phosphon
irrevers
dipeptid
kubiak
et
al
kubiak
et
al
mentlein
et
al
hae
gpv
evect
proost
et
al
aminoacylpyrrolidid
revers
villhauer
et
al
natur
peptid
ntermin
xaaxaapro
sequenc
less
strong
inhibitor
dpp
iv
eg
peptid
yy
tat
protein
human
immunodefici
viru
wrenger
et
al
mammalian
dpp
iv
cleav
varieti
regulatori
peptidesneuropeptid
peptid
hormon
chemokin
tabl
vi
ntermin
truncat
inactiv
partial
inactiv
certain
receptor
subtyp
evect
unknown
evect
biolog
activ
peptid
regulatori
peptid
xaapropro
sequenc
eg
bradykinin
rpp
residu
longer
peptid
eg
apt
residu
apv
residu
cleav
mentlein
activ
peptid
precursor
dpp
iv
cleavag
dpp
ivlik
enzym
observ
lower
vertebr
invertebr
eg
process
prohormon
caerulein
frog
xenopu
laevi
antifreez
protein
winter
flounder
proceropin
antibacteri
peptid
moth
promelittin
bee
venom
honeybe
preprohormon
sea
anemon
martensen
et
al
rel
degrad
rate
diver
peptid
vari
consider
report
substrat
cleav
prolong
incub
time
vitro
lambeir
et
al
mentlein
therefor
physiolog
signific
dpp
iv
truncat
remain
question
substrat
eg
glucagon
chemokin
howev
pivot
role
dpp
iv
final
partial
inactiv
peptid
hormon
gip
peptid
yy
neuropeptid
neuropeptid
substanc
p
vivo
evid
chemokin
function
dpp
iv
truncat
vivo
yet
proven
may
anticip
mdc
itac
least
certain
physiolog
condit
circul
peptid
hormon
expos
larg
quantiti
dpp
iv
surfac
endotheli
cell
comparison
solubl
serum
dpp
iv
leukocyt
less
total
activ
mentlein
contribut
hormon
degrad
import
physiolog
pharmacolog
dpp
iv
substrat
date
incretin
hormon
gip
belong
famili
residu
peptid
glucagon
peptid
famili
penultim
ala
name
grh
gip
phm
good
dpp
iv
substrat
lambeir
et
al
mentlein
et
al
penultim
ser
name
glucagon
secretin
vip
rel
poor
substrat
hink
et
al
lambeir
et
al
discuss
glucagonlik
formerli
nh
glucagonlik
respect
gastrointestin
peptid
hormon
releas
postprandi
enteroglucagon
cell
l
cell
small
larg
intestin
gener
altern
posttransl
process
proglucagon
posit
human
proglucagon
precursor
stimul
insulin
secret
vitro
vivo
play
import
role
regul
postprandi
insulin
releas
import
incretin
insulinotrop
hormon
known
far
fig
patient
type
diabet
exogen
lower
postprandi
plasma
glucos
excurs
stimul
insulin
releas
inhibit
glucagon
secret
sinc
biolog
halflif
short
use
exogen
prolong
action
consid
new
possibl
treatment
patient
type
diabet
also
produc
brain
intracerebroventricular
rodent
potent
inhibitor
food
water
intak
display
intestin
growth
factor
activ
rodent
rais
possibl
may
therapeut
use
enhanc
mucos
regener
patient
intestin
diseas
drucker
drucker
understand
inactiv
therefor
potenti
therapeut
interest
sever
studi
vitro
vivo
shown
primarili
degrad
nterminu
action
dpp
iv
result
biolog
inact
de
hisala
deacon
et
al
deacon
et
al
b
kiever
et
al
mentlein
et
al
subcutan
intraven
administr
healthi
type
diabet
human
recov
plasma
de
hisala
deacon
et
al
intraven
inject
iradiolabel
picomolar
concentr
rat
metabol
de
hisala
within
min
dpp
ivneg
rat
kiever
et
al
convers
could
block
vitro
vivo
specif
dpp
iv
inhibitor
diprotin
lysor
valpyrrolidid
pharmacolog
inhibit
dpp
iv
valinepyrrolidid
anesthet
pig
dose
reduc
plasma
dpp
iv
activ
increas
amount
intact
basal
state
infus
deacon
et
al
moreov
inhibit
dpp
iv
ilethiazolidid
zucker
rat
potenti
insulinotrop
evect
intraven
infus
alon
glucos
pederson
et
al
furthermor
glucos
toler
insulin
secret
enhanc
dpp
iv
knockout
mice
marguet
et
al
dpp
iv
activitydefici
fischer
rat
nagakura
et
al
comparison
normal
mice
fischer
rat
howev
inhibit
dpp
iv
normal
anim
show
similar
evect
meanwhil
improv
glucos
toler
dpp
iv
inhibit
also
proven
human
et
al
therefor
inhibit
dpp
iv
regard
valid
target
treatment
type
diabet
like
also
easili
degrad
de
hisala
purifi
human
dpp
iv
serum
contain
dpp
iv
activ
drucker
et
al
well
rat
human
vivo
hartmann
et
al
tavar
et
al
inject
normal
rat
induc
increas
intestin
villu
height
small
trophic
evect
small
bowel
weight
administr
dpp
ivdefici
rat
markedli
increas
bioactiv
rat
result
signific
increas
small
bowel
weight
drucker
et
al
dpp
ivresist
analogu
show
higher
evect
wildtyp
anim
eg
statist
signific
increas
small
bowel
mass
produc
analogu
r
gli
rat
human
analogu
h
gli
mice
drucker
et
al
b
result
show
inactiv
dpp
iv
critic
import
growth
factor
properti
intestin
dpp
ivresist
analogu
may
use
therapeut
improv
mucos
regener
gastric
inhibitori
polypeptid
glucosedepend
insulinotrop
polypeptid
gip
acid
polypeptid
secret
duoden
k
cell
ingest
fat
glucos
inhibit
secret
gastric
acid
stimul
insulin
releas
pancreat
b
cell
presenc
elev
glucos
level
thu
addit
gip
also
contribut
incretin
activ
postprandi
serum
fig
rodent
less
human
meier
et
al
member
grhglucagon
famili
penultim
ala
gip
also
rapidli
degrad
gip
purifi
human
dpp
iv
serum
dpp
iv
activ
vitro
mentlein
et
al
vivo
deacon
et
al
truncat
gip
serum
could
success
inhibit
coincub
specif
dpp
iv
inhibitor
vitro
vivo
deacon
et
al
kiever
et
al
mentlein
et
al
gip
also
detect
purif
gip
pig
intestin
rnvall
et
al
later
shown
lack
biolog
activ
even
weak
gip
receptor
antagonist
vivo
gault
et
al
schmidt
et
al
report
gip
also
rapidli
degrad
vivo
truncat
form
min
inject
radioiodin
gip
wildtyp
rat
dpp
ivdefici
one
kiever
et
al
accord
oral
administr
dpp
iv
inhibitor
halflif
gip
prolong
wildtyp
rat
pig
deacon
et
al
kiever
et
al
dpp
ivresist
analogu
potent
normal
obes
rat
hink
et
al
thu
dpp
iv
truncat
also
main
degrad
rout
gip
vivo
growth
hormonereleas
hormon
grh
peptid
biolog
activ
ctermin
truncat
fragment
known
releas
hypothalamu
stimul
releas
synthesi
growth
hormon
pituitari
human
plasma
grh
nh
fragment
rapidli
metabol
grh
nh
minor
degrad
product
deriv
endoproteolyt
cleavag
arg
ly
ly
val
bond
frohman
et
al
proteolyt
fragment
biolog
inact
use
specif
inhibitor
dpp
iv
trypsinlik
endoproteas
identifi
proteas
respons
process
follow
initi
report
dpp
ivmedi
proteolysi
establish
major
rout
grh
degrad
inactiv
rat
boulang
et
al
porcin
bovin
plasma
vitro
cattl
vivo
kubiak
friedman
kubiak
et
al
dpp
ivresist
peptid
analogu
grh
show
similar
biolog
activ
induc
growth
hormon
releas
vitro
cultiv
pituitari
cell
higher
potenc
increas
serum
growth
hormon
level
vivo
min
inject
cattl
due
longer
stabil
vivo
kubiak
friedman
peptid
yy
pyy
produc
endocrin
cell
small
intestin
colon
releas
meal
peptid
hormon
circul
blood
inhibit
sever
gastrointestin
function
eg
gastric
acid
releas
amino
termin
sequenc
tyrpro
conserv
neuropeptid
pyy
among
vertebr
speci
appear
best
peptid
substrat
dpp
iv
although
pyy
rapidli
cleav
human
serum
purifi
dpp
iv
vitro
mentlein
et
al
pyy
fragment
product
major
molecular
form
pyy
extract
human
rabbit
intestin
eberlein
et
al
circul
blood
grandt
et
al
physiolog
consequ
explor
among
neuropeptid
degrad
dpp
iv
substanc
p
neuropeptid
tabl
vi
neuropeptid
npi
probabl
interest
substrat
togeth
pyy
pancreat
polypeptid
pp
belong
peptid
famili
peptid
high
homolog
primari
tertiari
structur
npi
abund
neuropeptid
central
peripher
nervou
system
involv
control
feed
energi
homeostasi
blood
pressur
pyy
npi
also
rapidli
degrad
dpp
iv
vitro
de
tyrpro
npi
mentlein
et
al
truncat
form
identifi
consider
part
total
npi
extract
porcin
brain
grandt
et
al
human
cerebrospin
fluid
nilsson
et
al
fulllength
npi
pyy
pp
bind
diver
ayniti
least
five
receptor
subtyp
pyy
pyy
three
ntermin
truncat
npi
pyy
lack
ayniti
receptor
gerald
et
al
locat
cerebr
cortex
vascular
smooth
muscl
cell
promot
vasoconstrict
cell
prolifer
due
receptor
subtypespecif
regul
npi
activ
dpp
iv
alreadi
term
npyconvert
enzym
respect
dpp
iv
appear
involv
regul
vascular
smooth
muscl
contract
angiogenesi
zukowskagrojec
et
al
particular
endotheli
cell
migrat
ghersi
et
al
edema
dimitrijev
et
al
substanc
p
widespread
neuropeptid
act
eg
transmitt
sensori
inform
includ
noxiou
stimuli
potent
contractor
smooth
muscl
immunoregul
three
diver
gproteincoupl
receptor
subtyp
nk
nk
nk
known
also
stimul
neurokinin
b
share
common
ctermin
pentapeptid
sequenc
phexaaglyleumetnh
substanc
p
therefor
sequenti
liber
dipeptid
argpro
lyspro
nterminu
undecapeptid
substanc
p
heymann
mentlein
kato
et
al
abolish
biolog
activ
tachykinin
receptor
howev
fragment
substanc
p
lower
bind
activ
prefer
substanc
p
receptor
nk
receptor
mussap
et
al
evect
first
four
residu
substanc
p
essenti
eg
degranul
mast
cell
probabl
nonreceptormedi
pertub
membran
may
complet
abolish
dpp
iv
cleavag
howev
substanc
p
truncat
dpp
iv
attack
aminopeptidas
n
import
degrad
pathway
human
plasma
vascular
endothelium
fibroblast
muscl
myocyt
wang
et
al
wang
et
al
may
explain
potenti
neurogen
inflamm
enhanc
vasodil
dpp
iv
inhibitor
nasal
mucosa
grouzmann
et
al
ypwfnh
ypffnh
endogen
opioid
peptid
high
ayniti
opioid
receptor
produc
potent
analgesia
mice
dpp
iv
liber
termin
tyrpro
high
activ
wherea
analogu
dpro
penultim
posit
resist
analogu
potent
longer
last
induc
analgesia
vivo
moreov
dpp
iv
inhibitor
elicit
analgesia
potenti
action
shane
et
al
result
suggest
role
dpp
iv
endomorphin
inactiv
vivo
among
chemokin
cleav
dpp
iv
tabl
vi
itac
mdc
appear
import
sinc
cleav
highest
rate
lambeir
et
al
chemokin
constitut
larg
group
small
kda
secret
protein
act
celltypeselect
chemoattract
divid
four
subfamili
base
structur
function
genet
criteria
two
import
subfamili
cxc
cc
chemokin
aand
bfamili
diver
space
first
two
cystein
residu
form
disulfid
link
two
cystein
cxc
chemokin
first
cystein
residu
separ
one
amino
acid
cc
chemokin
directli
neighbor
gener
dpp
iv
cleavag
chemokin
abolish
chemotact
activ
case
truncat
form
act
weak
antagonist
howev
experiment
evid
given
import
process
vivo
dpp
iv
inhibitor
often
show
antiinflammatori
evect
steinbrech
et
al
potenti
inflammatori
respons
expect
prolong
chemokin
action
accord
dpp
iv
inhibitor
enhanc
chemotaxi
itac
activ
human
cell
vitro
express
dpp
iv
chemokin
receptor
howev
diver
result
found
chemotact
evect
human
cord
blood
progenitor
cell
also
coexpress
dpp
receptor
christopherson
et
al
conclus
sever
circul
hormon
gip
grh
pyy
neuropeptid
npi
substanc
p
endomorphin
chemokin
other
role
dpp
iv
complet
receptor
subtypespecif
inactiv
well
document
pharmacolog
import
action
despit
multipl
function
degrad
sever
regulatori
peptid
invas
tumor
dpp
iv
present
mainli
consid
new
valid
target
treatment
type
diabet
augustyn
et
al
drucker
holst
holst
deacon
prolong
action
inhibit
degrad
applic
dpp
ivresist
analogu
shown
enhanc
insulin
secret
glucos
toler
vivo
analogu
modifi
ntermin
ala
glu
correspond
dor
diver
amino
acid
eg
dala
longer
halfliv
consequ
higher
insulinotrop
potenc
vitro
vivo
burcelin
et
al
deacon
et
al
siegel
et
al
b
though
modif
rather
specif
approach
type
diabet
low
side
evect
drawback
peptid
analogu
given
oral
contrast
small
dpp
iv
inhibitor
augustyn
et
al
potenti
side
evect
howev
recent
clinic
studi
oral
activ
dpp
iv
inhibitor
type
diabet
patient
show
consider
better
insulin
toler
improv
hba
level
week
treatment
et
al
side
evect
surprisingli
low
partli
nasopharyng
pruritu
transient
nephrit
syndrom
thu
dpp
iv
inhibitor
appear
promis
drug
treatment
stage
type
diabet
apart
function
regulatori
proteas
import
role
dpp
iv
report
intestin
renal
ddp
iv
involv
final
digest
prolinecontain
oligopeptid
absorpt
fragment
brandsch
et
al
dpp
iv
also
act
costimulatori
bind
protein
dpp
iv
shown
ident
cellsurfac
marker
thymocyteactiv
molecul
tham
mous
homologu
antigen
express
fraction
rest
cell
low
densiti
strongli
upregul
follow
cell
activ
dang
morimoto
gorrel
et
al
morimoto
schlossman
reinhold
et
al
von
bonin
et
al
iv
deliv
potent
costimulatori
activ
signal
cell
despit
small
cytoplasm
region
six
amino
acid
signal
depend
interact
molecul
associ
presum
extracellular
domain
protein
tyrosin
phosphatas
adenosin
deaminas
ada
ec
enzym
involv
salvag
purin
nucleosid
catalyz
deamin
adenosin
deoxyadenosin
inosin
deoxyinosin
whose
defici
caus
sever
combin
immunodefici
diseas
scid
human
dpp
iv
adenosin
deaminas
complex
protein
adabp
moreov
signal
depend
express
cell
receptor
tcr
complex
tumor
cell
endotheli
cell
trophoblast
dpp
iv
express
associ
lower
invas
metastat
potenti
cheng
et
al
kajiyama
et
al
sato
et
al
shingu
et
al
wesley
et
al
could
evect
attribut
interact
extracellular
matrix
substanc
eg
collagen
iii
dpp
iv
bind
via
cysteinerich
domain
catalyt
site
fibronectin
ster
et
al
dual
function
dpp
iv
proteas
bindingstimulatori
molecul
sustain
structur
homolog
protein
either
one
function
report
see
past
year
sever
dpp
iv
activ
andor
structur
homologu
dash
protein
discov
sedo
malik
appear
rediscov
protein
new
name
follow
activ
homologu
also
cleav
chromogenicfluorogen
dpp
iv
substrat
solubl
enzym
dipeptidyl
peptidas
ii
dpp
ii
ec
appear
ident
leit
et
al
quiescent
cell
prolin
peptidas
qpp
dipeptidyl
peptidas
dpp
vii
dpp
ii
solubl
lysosom
protein
kda
consist
two
subunit
cleav
acid
ph
short
xaaproala
peptid
mentlein
struckhov
dipeptidyl
peptidas
cytosol
protein
activ
neutral
ph
dpp
iv
activ
abbott
et
al
might
ident
dipeptidyl
peptidas
ivb
dipeptidyl
peptidas
relat
dpp
cytosol
protein
dpp
iv
activ
olsen
wagtmann
follow
structur
homologu
cellsurfac
protein
either
lack
enzymat
activ
exhibit
diver
spectrum
attractin
mahogani
homolog
dpptl
type
transmembran
protein
four
secret
isoform
produc
altern
splice
gunn
et
al
express
secret
activ
cell
low
level
tissu
attractin
probabl
low
dpp
iv
activ
whether
also
cleav
peptid
thoroughli
investig
protein
suppos
involv
initi
immun
cell
cluster
inflammatori
respons
may
regul
chemotact
activ
chemokin
furthermor
may
play
role
melanocortin
signal
pathway
regul
energi
homeostasi
hair
color
fibroblast
activ
protein
fap
sepras
type
ii
transmembran
protein
subunit
homolog
human
sequenc
dpp
iv
act
mainli
endopeptidas
extracellular
matrix
protein
tabl
v
barrett
et
al
goldstein
et
al
scanlan
et
al
normal
tissu
fap
found
fetal
mesenchym
cell
subset
glucagonproduc
cell
cell
pancreat
islet
howev
activ
fibroblast
either
cultiv
wound
tumor
cultiv
melanocyt
sarcoma
cell
express
fap
biolog
function
clarifi
suspect
fap
involv
wound
heal
due
select
occurr
fap
good
target
tumor
immunodetect
destruct
tumor
therapi
dpp
iv
fap
resid
neighbor
gene
locu
tabl
v
may
therefor
origin
gene
duplic
form
homodim
usual
occur
togeth
glutam
carboxypeptidas
ii
gcpii
ec
nacetyl
alink
acid
dipeptidas
naaladas
also
folat
hydrolas
pteroylpolygglutam
carboxypeptidas
type
ii
transmembran
protein
amino
acid
kda
barrett
et
al
releas
unsubstitut
ctermin
glutamyl
residu
acaspglu
pteroylg
particular
hydrolyz
gpeptid
bond
acaspglu
aspglu
gluglu
also
gglutamyl
bond
ggluglu
folylpolygglutam
accord
recent
investig
dpp
iv
activti
barinka
et
al
enzym
requir
zink
per
subunit
activ
cobalt
inhibit
quisqual
acid
phosphonomethyl
pentanedio
acid
pmpa
edta
primari
sourc
prostat
epithelium
well
small
intestin
specif
jejunum
brush
border
membran
brain
ventral
striatum
brain
stem
kidney
liver
spleen
colon
capillari
endothelium
varieti
tumor
prostat
cytosol
isoform
term
psma
produc
altern
splice
abund
normal
tissu
membranebound
prostatespecif
membran
antigen
diver
prostatespecif
antigen
psa
found
primari
prostat
tumor
physiolog
function
gppiinaaladas
requir
uptak
folat
intestin
brain
modul
excitatori
neurotransmiss
hydrolysi
neuropeptid
nacetylaspartylglutam
naag
therebi
releas
glutam
psma
use
diagnost
prognost
indic
prostat
cancer
possibl
marker
variou
neurolog
disord
schizophrenia
alzheim
diseas
huntington
diseas
gppiinaaldas
inhibitor
analget
yamamoto
et
al
neuroprotect
evect
william
et
al
naaladas
ii
iii
similar
former
enzym
pangalo
et
al
dipeptidylpeptidaselik
protein
exist
two
altern
splice
form
dppxl
dppx
type
ii
transmembran
protein
wada
et
al
due
substitut
aspart
residu
serin
residu
propos
catalyt
triad
dipeptidyl
aminopeptidas
activ
express
predominantli
brain
may
involv
brain
function
dipeptidyl
peptidas
anoth
type
ii
transmembran
protein
amino
acid
high
homolog
dpp
iv
qi
et
al
howev
activ
serin
replac
serin
therefor
lack
dipeptidyl
peptidas
activ
protein
mainli
express
brain
pancrea
cellsurfac
oligo
peptidas
initi
character
digest
clear
enzym
although
cleav
peptid
upto
residu
regard
regulatori
proteas
control
activ
inactiv
circul
hormon
neuropeptid
consequ
ace
nep
ece
dpp
iv
futur
probabl
app
cpm
other
valid
drug
target
inhibitor
peptidaseresist
analogu
alreadi
wide
use
drug
develop
mostli
hypertens
diabet
type
futur
area
appear
treatment
pain
inflammatori
diseas
despit
widespread
propos
clinic
use
inhibitor
littl
known
defect
mutat
cellsurfac
peptidas
gene
regul
express
diseas
cellsurfac
peptidas
also
attract
attent
diagnosi
especi
diverenti
hematopoiet
cell
leukemia
although
distribut
widespread
endotheli
cell
frequent
local
correspond
role
inactiv
enzym
hormon
work
need
explor
express
diver
type
vessel
probabl
function
diagnost
role
angiogenesi
research
past
year
made
evid
integr
membranebound
peptidas
belong
gene
famili
includ
solubl
often
similar
peptidas
well
integr
membran
protein
either
proteas
diver
specif
act
bind
protein
similar
nonenzymat
function
bind
protein
also
discov
cellsurfac
peptidas
evid
particip
cell
invas
adher
even
signal
transduct
receptor
protein
appear
nonenzymat
function
mostli
relat
catalyt
site
domain
molecul
involv
futur
research
need
identifi
bind
target
especi
physiolog
relev
interact
conclus
cellsurfac
peptidas
key
regul
inactiv
activ
hormon
neuropeptid
although
peptid
bond
specif
peptid
specif
inhibitor
becom
becom
drug
also
knowledg
concern
specif
action
import
design
peptidaseresist
regulatori
peptid
emerg
field
research
role
bind
protein
especi
cell
adher
invas
